Jason D. Fontenot's Net Worth
$168 Thousand
Who is Jason D. Fontenot?
Jason D. Fontenot does not have any significant net worth to report based on the numbers we have. This is based on reported shares in SANGAMO THERAPEUTICS, INC.
SEC CIK
Jason D. Fontenot's CIK is 0001851761
Past Insider Trading and Trends
2022 was Jason D. Fontenot's most active year for acquiring shares with 2 total transactions. Jason D. Fontenot's most active month to acquire stocks was the month of January. 2023 was Jason D. Fontenot's most active year for disposing of shares, totalling 4 transactions. Jason D. Fontenot's most active month to dispose stocks was the month of January. 2023 saw Jason D. Fontenot paying a total of $0.00 for 242,250 shares, this is the most they've acquired in one year. In 2022 Jason D. Fontenot cashed out on 7,074 shares for a total of $40,852.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.72
SVP, Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.75% | -1.03K |
$0.38 | -$393.56 | 136.27K |
Nov 25
| |||
Form 4
| -0.74% | -1.03K |
$0.77 | -$792.33 | 137.3K |
Aug 25
| |||
Form 4
| -0.74% | -1.03K |
$1.33 | -$1,368.57 | 138.33K |
May 25
| |||
Form 4
| +35.08% | 36.19K |
$2.66 | -$17,446.94 | 139.36K |
Feb 24 - Feb 25
| |||
Form 4
| -0.79% | -826.00 |
$4.83 | -$3,989.58 | 103.17K |
Apr 25
| |||
Form 4
| +59.64% | 38.85K |
$5.90 | -$36,863.20 | 103.99K |
Feb 25
| |||
Form 4
| -1.28% | -811.00 |
$11.71 | -$9,496.81 | 62.5K |
Apr 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||